We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.07%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$1.2M
(+0.6%)
Cap. Flow
+$4.13M
Cap. Flow
% of AUM
2.04%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
59
New
11
Increased
16
Reduced
17
Closed
14
Top Buys
| 1 |
Cue Biopharma
CUE
|
+$7.68M |
| 2 |
Aurinia Pharmaceuticals
AUPH
|
+$7.29M |
| 3 |
Baxter International
BAX
|
+$6.69M |
| 4 |
Prothena Corp
PRTA
|
+$6.56M |
| 5 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
+$5.31M |
Top Sells
| 1 |
Kura Oncology
KURA
|
+$12.8M |
| 2 |
Arrowhead Research
ARWR
|
+$4.93M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$4.28M |
| 4 |
Aldeyra Therapeutics
ALDX
|
+$3.41M |
| 5 |
Vericel Corp
VCEL
|
+$2.9M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Technology | 4.47% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
iShares S&P 100 ETF
OEF
$20.5B
| – | – |
0
| – | – |
|
52
Pacira BioSciences
PCRX
$993M
| – | – |
-55,000
| Closed | -$2.89M |
|
53
Personalis
PSNL
$1.57B
| – | – |
-188,750
| Closed | -$2.45M |
|
54
United Therapeutics
UTHR
$22.6B
| – | – |
-15,000
| Closed | -$1.81M |
|
|
55
Vericel Corp
VCEL
$2.42B
| – | – |
-209,897
| Closed | -$2.9M |
|
56
Xeris Biopharma Holdings
XERS
$1.47B
| – | – |
-419,469
| Closed | -$1.12M |
|
|
LHCG
57
DELISTED
LHC Group LLC
LHCG
| – | – |
-4,509
| Closed | -$786K |
|
|
TPTX
58
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| – | – |
-25,602
| Closed | -$1.65M |
|
|
MGLN
59
DELISTED
Magellan Health Services, Inc.
MGLN
| – | – |
-5,200
| Closed | -$379K |
|
Similar funds
PL
BFC
ACM
FFWA
SAM
CBB
AIG
IA